Arid5a stabilizes OX40 mRNA in CD4+ T cells, promoting IL-17 production and contributing to the pathogenesis of autoimmune diseases like EAE.
Arid5a inhibition merits exploration as an MS target; animal findings leave open human translation.
AT‐rich interactive domain‐containing protein 5a (Arid5a) is an RNA‐binding protein (RBP) required for autoimmunity via stabilization of interleukin‐6 ( Il6 ) and signal transducer and activator of transcription 3 ( STAT3 ) mRNAs. However, the roles of Arid5a in Th17 cells and its association with autoimmunity remain unknown. Here, we show that the levels of Arid5a and OX40 are correlated in CD4 + T cells under Th17 conditions in an IL‐6‐dependent manner. Lack of Arid5a in T cells reduced OX40 expression levels and repressed IL‐17 production in response to OX40 ligation. Arid5a stabilized OX40 mRNA by recognizing the alternative decay element (ADE)‐like stem‐loop (SL) in the 3′ untranslated region (3′UTR). Interestingly, Arid5a impaired the RNA‐destabilizing functions of Regnase‐1 and Roquin‐1 on OX40 ADE‐like SL. In EAE, Arid5a‐deficient mice exhibited resistance to EAE, with reduced OX40 expression in CD4 + T cells, and the number of CD4 + CD45 + T cells was decreased in CNS. Furthermore, ameliorated EAE was induced by adoptive transfer of Arid5a −/− encephalitogenic CD4 + T cells expressing less OX40 mRNA and producing less IL‐17. In conclusion, our findings indicate that the Arid5a/OX40 axis in CD4 + T cells may have important implications in pathogenesis of autoimmune diseases such as EAE.
No takes yet. Share an insight, caveat, or question.
Hanieh et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: